$1.17 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 114 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | $15,887,000 | +27.1% | 518,834 | 0.0% | 1.36% | +31.1% | |
| INDA | ISHARES TRmsci india etf | $4,724,000 | +4.7% | 134,400 | 0.0% | 0.40% | +8.0% | |
| MASI | MASIMO CORP | $1,138,000 | +6.3% | 7,200 | 0.0% | 0.10% | +9.0% | |
| LLY | LILLY ELI & CO | $974,000 | +17.5% | 7,413 | 0.0% | 0.08% | +20.3% | |
| SZC | CUSHING RENAISSANCE FD | $432,000 | +2.1% | 31,877 | 0.0% | 0.04% | +5.7% | |
| PPR | VOYA PRIME RATE TRsh ben int | $248,000 | +6.4% | 49,500 | 0.0% | 0.02% | +10.5% | |
| DEX | DELAWARE ENHANCED GBL DIV & | $206,000 | +5.6% | 19,818 | 0.0% | 0.02% | +12.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 37 | Q3 2023 | 5.0% |
| MICROSOFT CORP | 35 | Q3 2023 | 5.5% |
| CITIGROUP INC | 33 | Q2 2021 | 5.8% |
| JPMORGAN CHASE & CO | 33 | Q3 2023 | 3.2% |
| D R HORTON INC | 32 | Q3 2023 | 3.2% |
| TRANSDIGM GROUP INC | 32 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
| JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
| VERACYTE INC | 31 | Q2 2023 | 0.8% |
| LENNAR CORP | 30 | Q1 2022 | 2.7% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
| Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
| Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
| CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
| HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
| Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
| VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
| Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
| MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
| BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.